Literature DB >> 22487871

The effect of ethnicity and sexual preference on prostate-cancer-related quality of life.

Nir Kleinmann1, Nicholas G Zaorsky, Timothy N Showalter, Leonard G Gomella, Costas D Lallas, Edouard J Trabulsi.   

Abstract

In general, patients with prostate cancer are able to maintain a relatively high quality of life (QOL), commonly reporting improvements in physical, emotional, and social functioning within 1 year of treatment. However, certain subpopulations of patients are susceptible to significant reductions in QOL during the course of their treatment. Data suggest that ethnic background and sexual preference both have significant effects on QOL for patients with prostate cancer. These parameters are often poorly documented and addressed by medical practitioners. Greater attention is needed to identify patients who are at increased risk of QOL reduction as a result of these factors.

Entities:  

Mesh:

Year:  2012        PMID: 22487871     DOI: 10.1038/nrurol.2012.56

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  76 in total

1.  A comparison of the Yale Physical Activity Survey with other physical activity measures.

Authors:  D R Young; S H Jee; L J Appel
Journal:  Med Sci Sports Exerc       Date:  2001-06       Impact factor: 5.411

2.  A survey for assessing physical activity among older adults.

Authors:  L Dipietro; C J Caspersen; A M Ostfeld; E R Nadel
Journal:  Med Sci Sports Exerc       Date:  1993-05       Impact factor: 5.411

Review 3.  The quality-of-life impact of prostate cancer treatments.

Authors:  Jaspreet Singh; Edouard J Trabulsi; Leonard G Gomella
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

4.  Brain response to putative pheromones in homosexual men.

Authors:  Ivanka Savic; Hans Berglund; Per Lindström
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

Review 5.  Quality of life in patients with localized prostate cancer.

Authors:  Marcus L Quek; David F Penson
Journal:  Urol Oncol       Date:  2005 May-Jun       Impact factor: 3.498

6.  Demography of immigrant youth: past, present, and future.

Authors:  Jeffrey S Passel
Journal:  Future Child       Date:  2011

7.  A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: development of stress management skills improves quality of life and benefit finding.

Authors:  Frank J Penedo; Ivan Molton; Jason R Dahn; Biing-Jiun Shen; Dave Kinsinger; Lara Traeger; Scott Siegel; Neil Schneiderman; Michael Antoni
Journal:  Ann Behav Med       Date:  2006-06

8.  Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.

Authors:  Louie E Ross; Zahava Berkowitz; Donatus U Ekwueme
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

9.  Defining sexual outcomes after treatment for localized prostate carcinoma.

Authors:  Leslie R Schover; Rachel T Fouladi; Carla L Warneke; Leah Neese; Eric A Klein; Craig Zippe; Patrick A Kupelian
Journal:  Cancer       Date:  2002-10-15       Impact factor: 6.860

Review 10.  On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer.

Authors:  Scott D Ramsey; Steven B Zeliadt; Ingrid J Hall; Donatus U Ekwueme; David F Penson
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

View more
  11 in total

1.  Radiation therapy to the primary tumor in locally advanced prostate cancer is not "closing the barn door after the horse has bolted".

Authors:  Nicholas G Zaorsky; Mark A Hallman; Marc C Smaldone
Journal:  Ann Transl Med       Date:  2015-10

Review 2.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

3.  Are HIV-infected men vulnerable to prostate cancer treatment disparities?

Authors:  Adam B Murphy; Ramona Bhatia; Iman K Martin; David A Klein; Courtney M P Hollowell; Yaw Nyame; Elodi Dielubanza; Chad Achenbach; Rick A Kittles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-25       Impact factor: 4.254

Review 4.  The evolution of brachytherapy for prostate cancer.

Authors:  Nicholas G Zaorsky; Brian J Davis; Paul L Nguyen; Timothy N Showalter; Peter J Hoskin; Yasuo Yoshioka; Gerard C Morton; Eric M Horwitz
Journal:  Nat Rev Urol       Date:  2017-06-30       Impact factor: 14.432

5.  Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis.

Authors:  Nicholas G Zaorsky; Charles T Lee; Eddie Zhang; Scott W Keith; Thomas J Galloway
Journal:  Radiother Oncol       Date:  2017-08-23       Impact factor: 6.280

6.  Men's health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer.

Authors:  Nicholas G Zaorsky; Thomas M Churilla; Karen Ruth; Shelly B Hayes; Mark L Sobczak; Mark A Hallman; Marc C Smaldone; David Yt Chen; Eric M Horwitz
Journal:  Am J Clin Nutr       Date:  2016-10-26       Impact factor: 7.045

7.  Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis.

Authors:  Nicholas G Zaorsky; Charles T Lee; Eddie Zhang; Thomas J Galloway
Journal:  Radiother Oncol       Date:  2018-01-19       Impact factor: 6.280

8.  Understanding Prostate Cancer in Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women: A Review of the Literature.

Authors:  B R Simon Rosser; Shanda L Hunt; Benjamin D Capistrant; Nidhi Kohli; Badrinath R Konety; Darryl Mitteldorf; Michael W Ross; Kristine M Talley; William West
Journal:  Curr Sex Health Rep       Date:  2019-11-08

9.  A prostate cancer model build by a novel SVM-ID3 hybrid feature selection method using both genotyping and phenotype data from dbGaP.

Authors:  Sait Can Yücebaş; Yeşim Aydın Son
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

Review 10.  A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.

Authors:  Vladimir Avkshtol; Yanqun Dong; Shelly B Hayes; Mark A Hallman; Robert A Price; Mark L Sobczak; Eric M Horwitz; Nicholas G Zaorsky
Journal:  Res Rep Urol       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.